ONCOLOGÍA RADIOTERÁPICA

2011

Artículos

Pérez-Regadera J, Sánchez Muñoz A, De la Cruz J, Ballestín C, Lora D, García Martín R, et al. Impact of epidermal growth factor receptor expression on disease-free survival and rate of pelvic relapse in patients with advanced cancer of the cervix treated with chemoradiotherapy. Am J Clin Oncol. 2011;34(4):395-400.

Congresos

Cascales García MA, Cabeza Rodríguez MA, Gascón Costoso N, Martínez Gutiérrez R, Rodríguez García S, Gómez Ordóñez S, et al. Long-term results of brachytherapy for carcinoma of the penis. Eur J Cancer. 2011;47(Suppl 1):S512 [European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care (Stockholm. 2011)]

.

2012

Artículos

Cabeza Rodríguez MA, Pérez Escutia MA, Rodríguez Antolín A, Gascón Costoso N, Cascales García A, Lanzós González E. Fenómeno de rebote de PSA después de tratamiento local con radioterapia en el cáncer de próstata. Arch Esp Urol. 2012;65(1):21-37

Guinot JL, Pérez Calatayud J, Azcoaga JM, Herruzo I, Bodineau C, Rovirosa A, et al.; SEOR and the SEFM Brachytherapy Groups. Consensus on treatment of endometrium carcinoma with brachytherapy. Clin Transl Oncol. 2012;14(4):263-70

Jaén J, Vázquez G, Alonso E, De las Peñas MD, Díaz L, De las Heras M, et al. Long-term changes in pulmonary function after incidental lung irradiation for breast cancer: a prospective study with 7-year follow-up. Int J Radiat Oncol Biol Phys. 2012;84(5):e565-70

Rodríguez Pérez A, López Carrizosa MC, Samper Ots PM, Pérez-Regadera Gómez JF, Zapatero Ortuño J, Sáez Garrido JD, et al. Conservative surgery, external radiotherapy, and HDR brachytherapy in a single fraction of 7 Gy in early breast cancer: long-term toxicity and esthetic assessment. Clin Transl Oncol. 2012;14(12):953-60

Rodríguez Pérez A, Samper Ots PM, López Carrizosa MC, Pérez-Regadera Gómez JF, Zapatero Ortuño J, Sáez Garrido JD, et al. Early-stage breast cancer conservative treatment: high-dose-rate brachytherapy boost in a single fraction of 700 cGy to the tumour bed. Clin Transl Oncol. 2012;14(5):362-8

Congresos

Cascales García M, Cabeza Rodríguez M, Gascón Costoso N, Pérez Escutia M, Rodríguez S, Bartolomé A, et al. Conservative treatment of penile cancer: retrospective analysis of 1 cohort of patients treated with brachytherapy. Int J Radiat Oncol Biol Phys. 2012;84(3):S422-S423 [Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO) (54. Boston, MA. 2012)]

D’Ambrosi R, Pérez-Regadera J, Gómez Ordóñez S, Hernández Arteaga O, Bartolomé A, Cabeza M, et al. Impact of radiological lymph node stage and extended field radiation therapy on survival in cervical cancer. Int J Radiat Oncol Biol Phys. 2012;84(3):S432-S4333 [Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO) (54. Boston, MA. 2012)]

Pérez-Regadera J, Gómez S, D’Ambrosi R, Rodríguez S, Gascón N, Colmenero N, et al. Impact of value of squamous cell carcinoma antigen (scc) in the survival of advanced cervical cancer, managed with chemoradiation therapy (CT-RT). Int J Radiat Oncol Biol Phys. 2012;84(3):S434 [Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO) (54. Boston, MA. 2012)]

Vázquez G, Jaén J, Alonso E, De las Peñas M, Díaz L, De las Heras M, et al. Late pulmonary injury after irradiation for lung cancer at 5-year follow-up. Int J Radiat Oncol Biol Phys. 2012;84(3):S583 [Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO) (54. Boston, MA. 2012)]

Vázquez G, Jaén J, Alonso E, De las Peñas M, Díaz L, De las Heras M, et al. Long-term changes in pulmonary function after incidental lung irradiation for breast cancer: a prospective study with 7-year follow-up. Int J Radiat Oncol Biol Phys. 2012;84(3):S190 [Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO) (54. Boston, MA. 2012)]

Vega E, Cascales A, De Velasco G, Cabeza Rodríguez MA, Parrilla L, Colmenero M, et al. Retrospective analysis of 132 patients with stage I seminoma: Observation versus adjuvant radiation or chemotherapy in a single institution. J Clin Oncol. 2012;30(15):e15033 [Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) (48. Chicago, IL. 2012)]

.

2013

Artículos

Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, et al.; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet. 2013;381(9869):805-16. Erratum in: Lancet. 2013;381(9869):804. Erratum in: Lancet. 2017;389(10082):1884

Meneses JC, Ávila Martínez RJ, Ponce S, Zuluaga M, Bartolomé A, Gámez P. Tratamiento del carcinoma broncogénico de célula no pequeña en estadios precoces. Cir Esp. 2013;91(10):625-32 [PubMed]

Tejerizo García A, Jiménez López JS, Muñoz González JL, Bartolomé Sotillos S, Marqueta Marqués L, López González G, et al. Overall survival and disease-free survival in endometrial cancer: prognostic factors in 276 patients. Onco Targets Ther. 2013;9:1305-13 [PubMed]

Congresos

Gómez Iturriaga A, Cabeza M, Pastor J, Jove J, Casana M, Mengual J, et al. Multi-institutional outcomes following external beam radiation therapy and androgen deprivation therapy in patients with extreme-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2013;87(2):S367-7 [Annual Meeting of the American Society for Radiation Oncology (55. Atlanta, GA. 2013)]

Muñoz García J, Cabeza Rodríguez MA, Jove i Teixido J, López Torrecilla J, Hervás Morón A, Henríquez López I, et al. Whole pelvic radiation therapy versus prostate only in patients with intermediate-, high-, and very high-risk prostate cancer according NCCN criteria treated with radical intention: Recap Data Base. Int J Radiat Oncol Biol Phys. 2013;87(2):S361 [Annual Meeting of the American Society for Radiation Oncology (55. Atlanta, GA. 2013)]

Ruiz Solís S, Sarandeses Fernández P, Hernández Martínez A, Cotrina Monroy P, Lechuga C, Pérez-Regadera J, et al. 18F-FDG PET/CT in patients with locally advanced cervical cancer. Correlation between SUVmax and overall survival, microvessel density and cell proliferation. A preliminary study. Eur J Nucl Med Mol Imaging. 2013;40(Suppl 2):S368 [Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) (Lyon. 2013)]

Zapatero A, Guerrero A, Maldonado X, Álvarez A, San Segundo CG, Cabeza M, et al. Late side effects in men with intermediate- and high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation (DART 01/05): Secondary endpoints from a phase 3 clinical trial. Int J Radiat Oncol Biol Phys. 2013;87(2):S105 [Annual Meeting of the American Society for Radiation Oncology (55. 2013. Atlanta, GA.)]

.

2014

Artículos

Cerezo L, De la Torre A, Hervás A, Ruiz A, Liñán O, López M, et al. Oropharyngeal cancer related to Human Papilloma Virus: incidence and prognosis in Madrid, Spain. Clin Transl Oncol. 2014;16(3):301-6 [PubMed]
JCR Factor de Impacto: 2,077
JCR Cuartil: Q3
JCR Decil: D8
JCR Posición: 148/211
JCR Categoría: ONCOLOGY

Cerezo L, López C, De la Torre A, Suárez D, Hervas A, Ruiz A, et al. Incidence of human papillomavirus-related oropharyngeal cancer and outcomes after chemoradiation in a population of heavy smokers. Head Neck. 2014;36(6):782-6 [PubMed]
JCR Factor de Impacto: 2,641
JCR Cuartil: Q1
JCR Decil: D3
JCR Posición: 48/198
JCR Categoría: SURGERY

Hilario A, Sepúlveda JM, Pérez Núñez A, Salvador E, Millán JM, Hernández Laín A, et al. A prognostic model based on preoperative MRI predicts overall survival in patients with diffuse gliomas. AJNR Am J Neuroradiol. 2014;35(6):1096-102 [PubMed]
JCR Factor de Impacto: 3,589
JCR Cuartil: Q1
JCR Decil: D3
JCR Posición: 43/192
JCR Categoría: CLINICAL NEUROLOGY

.

2015

Artículos

Lanzós I, Herrera D, Lanzós E, Sanz M. A critical assessment of oral care protocols for patients under radiation therapy in the regional University Hospital Network of Madrid (Spain). J Clin Exp Dent. 2015;7(5):e613-21 [PubMed]

López Torrecilla J, Boladeras A, Cabeza MA, Zapatero A, Jove J, Esteban LM, et al. Three linked nomograms for predicting biochemical failure in prostate cancer treated with radiotherapy plus androgen deprivation therapy. Strahlenther Onkol. 2015;191(10):792-800 [PubMed]

Luna J, Amaya E, De Torres MV, Peña MC, Prieto I. Nutrientes y radioterapia: revisión de la literatura. Nutr Hosp. 2015;32(6):2446-59 [PubMed]

Zapatero A, Guerrero A, Maldonado X, Álvarez A, Segundo CGS, Cabezas Rodríguez MA, et al. High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial. Lancet Oncol. 2015;16(3):320-7 [PubMed]

Responder

Introduce tus datos o haz clic en un icono para iniciar sesión:

Logo de WordPress.com

Estás comentando usando tu cuenta de WordPress.com. Cerrar sesión /  Cambiar )

Google photo

Estás comentando usando tu cuenta de Google. Cerrar sesión /  Cambiar )

Imagen de Twitter

Estás comentando usando tu cuenta de Twitter. Cerrar sesión /  Cambiar )

Foto de Facebook

Estás comentando usando tu cuenta de Facebook. Cerrar sesión /  Cambiar )

Conectando a %s